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Abstract: Objective: Vepesid is a
semisynthetic derivative of phodophylotoxin
extracted from Phodophylum peltatum, which
is in the group of plant alkaloids. In this study,
the antiviral effect of Vepesid against herpes
simplex virus type 2 (HSV-2) in in vitro
conditions was investigated.
Materials and Methods: In this investigation,
a HEp-2 continuous cell line that was derived
from human larynx cancer cells was used. The
experiments were done in culture plates with
smooth bases consisting of 96 wells.
Cultivation of cells was realized in EMEM
medium with 10% fetal bovine serum at an
atmosphere of 37°C with 5% CO2. The
toxicity of investigated agents and sensitivity
of HEp-2 cells were evaluated according to
the Reed and Muench method. The 50%
effective dose (ED50) of the antiviral agent
was expressed as the concentration that
inhibits the cytopathological effect in half of
the quadruplicate test cultures. Acyclovir was
included as a positive control drug for HSV.
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The experiments were done in two stages. In
the first stage, the concentration of Vepesid
that did not affect proliferation was
determined by means of morphological and

Introduction
The emergence of resistance against antiviral drugs
used in the treatment of HSV-1, HSV-2, varicella zoster
virus and cytomegalovirus infections, in patients with
immune deficiency, especially AIDS patients, poses serious
clinical and epidemiological problems (1,2). In recent
years, resistance to Acyclovir has been noted in patients
receiving cancer chemotherapy due to the treatment. This
leads to a more serious clinical cause and spread of the
disease. For this reason, new and alternative methods are
being sought for species that are resistant to Acyclovir
(3).

biochemical parameters (pH, pCO2, pO2, Na+).
In the second stage, the antiviral effect of that
dose was examined on 100 TCID50 of HSV-2.
Results: The concentrations of Acyclovir and
Vepesid (3.12 µg/ml, 6.28 µg/ml) were toxic
and 1.56 µg/ml of both agents did not affect
cell proliferation. These amounts of Acyclovir
and Vepesid inhibited viral reproduction and
had no cytopathological effect on cells. Na+
content of the culture medium was 138 ±
2.54 mEq/L for the control group, 126 ±
1.65 mEq/L for the virus control, 142 ± 0.3
for the Acyclovir, 142 ± 0.4 for the Acyclovir
+ virus, 143 ± 1.1 for Vepesid, 141 ± 0.2 for
the virus + Vepesid. LD50 of Acyclovir and
Vepesid was found to be 71% for a virus titer
of 100 TCID50.
Conclusion: We found that Vepesid prevented
the viral replication of herpes simplex virus
type 2. We think that the study of Vepesid as
the treatment for patients with herpes
simplex virus (HSV) is very important in terms
of its clinical and epidemiological nature.
Key Words: Vepesid, Acyclovir, HSV-2, lethal
dose, cell culture.

In view of this, the antiviral effects apart from the
anticarcinogenic effects of antineoplastic agents are of
clinical and epidemiologic importance. Studies on the
antiviral effects of the antineoplastic drugs used in the
treatment of cancer are insufficient. The presence of the
antiviral characteristics of these agents along with their
anticarcinogenic effects could prevent viral infections or
the emergence of species resistant to the antiviral drugs
(4,5).
In this study, the antiviral effects of Vepesid, the semisynthetic derivate of the plant alkaloid podophylotoxin,
against HSV-2 was examined in an HEp-2 continuous cell
culture.
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Materials and Methods
Preparation of the Cell Culture: Experiments were
carried out on an HEp-2 continuous cell culture derived
from human laryngeal epidermoid carcinoma. The HEp-2
continuous cell culture was obtained from the Virology
Department of the Ankara Refik Saydam Central Hifzisihha Institute. In preparing the cell culture, EMEM (Eagle’s
Minimum Essential Medium) (Sigma) containing 10%
fetal calf serum (Gibco) was used. Cultivation of cells was
realized at an atmosphere of 37°C with 5% CO2. The cells
were collected and washed with PBS (Phosphate Buffered
Saline) and then the surface of the culture cup was completely covered by the cells. Later, versen-trypsin solution
(containing 8g NaCI, 0.2 g KCI, 2.37g Na2HPO4 x 12
H2O, 0.2 g KH2PO4, 1 g titriplex III, 1.25 g trypsin per
liter) was added to cover the surface of the cells. The culture cups were kept at 37°C for 5-10 minutes to allow it
to grow and cover the surface of the culture cup. The dispersed cells were centrifugated at 1000 rpm for 10 minutes at + 4°C to remove the versene-trypsin solution.
From the pellet of cells precipitated at the bottom of the
centrifuge tube a final solution containing 300,000 cells
per milliliter was prepared with EMEM containing 10%
fetal calf serum.
Preparation of Drug Dilutions: Six different concentrations of Vepesid and Acyclovir were prepared by diluting with deionized water.
Acyclovir: 1.56 µg/ml, 3.12 µg/ml, 6.25 µg/ml, 12.5
µg/ml, 25 µg/ml, 37.5 µg/ml
Vepesid: 1.56 µg/ml, 3.12 µg/ml, 6.25 µg/ml, 12.5
µg/ml, 25 µg/ml, 37.5 µg/ml
Determination of the Viral Titration: The HSV-2
species to be determined was removed from liquid nitrogen and immediately dissolved in a 37°Cwater bath. Then
vortexing dilutions of 10-1-10-8 were made in PBS. One
hundred microliters of each dilution was then added to 4
wells of the microplate. On to them, 50 µl of the solution
containing 300,000 cells/ml, already prepared (with
EMEM containing 10% fetal calf serum) was added. Later
it was left at 37°C’in an atmosphere of 5% CO2 for incubation. Seventy-two hours after incubation, cells from the
wells were examined under a microscope for any cytopathic effects. The 100, 10 and 1 TCID50 (Tissue Culture
Infective Dose 50%) was calculated according to the
methods of Reed and Muench (6).

8

With the aim of determining the concentration of
drug not inhibiting the proliferation of cells, 50 µl from
each of the six different dilutions of Acyclovir and Vepesid
was placed in the 96 well culture plate (Nunc) and 50 µl
of the cell suspension (300,000 /ml) was added and incubated for 72 hours in 50 µl EMEM containing 10% fetal
calf serum.
Determination of the Concentration of Drug
Inhibiting Viral Proliferation:
Viral Inhibition Plate
Drug dilutions (µl/ml)
Diluted virus (100 TCID50)
Cell* (50 µl)
Culture Medium (50 µl)
* HEp-2 Cells: Human laryngeal cancer cells
Cell Control Plate
Drug dilutions (µl/ml)
Cell* (50 µl)
Culture Medium (50 µl)
* HEp-2 Cells: Human laryngeal cancer cells

Results
Acyclovir and Vepesid at concentrations of 3.12 µg/ml
and higher were found to induce clear cytopathic changes
such as enlargement of the nucleus, granulation and
rounding of the cells. In experiments in which Acyclovir
and Vepesid were used at concentrations of 1.56 µg/ml
no cytopathological effects were found. At this chosen
value, where cellular proliferation was not affected, the
optimal concentration, the measured biochemical values
(pH, CO2, O2) after incubation of the cell control groups
are shown in Figures 1 and 2.
The EMEM containing 10% fetal calf serum used in
the preparation of the HEp-2 cell culture and culture
medium taken after incubation of the cells for 72 hours
showed the important criteria in the growth and development of the cells as follows: pCO2: 5.6 mmHg, 21.2 ±
0.6 mmHg, pO2; 189 mmHg, 159 ± 2.9, Na+: 147.6
mEq/L, 151 ± 1.5 mEq/L, H+: 168 mEq/L, 201 ± 5.8
mEq/L, respectively.
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When the antiviral effects of the drugs of these concentrations against 100 TCID50 titer of HSV-2 were compared morphologically and biochemically with those of
the control group, they were found to inhibit viral reproduction. No cytopathic changes indicative of viral proliferation were found morphologically. The Na+ content of the
culture medium was 138 ± 2.54 mEq/L for the control
group, 126 ± 1.65 mEq/L for the virus control, 142 ±
0.3 for the Acyclovir, 142 ± 0.4 for the Acyclovir + virus,
143 ± 1.1 for Vepesid, and 141 ± 0.2 for the virus +
Vepesid (Figure 3). The following values were observed
for the other biochemical criteria: for the cell control,
pCO2: 21 ± 1.2 mmHg, pO2: 150±3.5 mmHg, H+: 202 ±

The Effect of Acyclovir and Vepesid against to HSV-2
according to sodium

4.4, for the virus control: pCO2: 5 ± 0.2 mmHg, pO2:
223 ± 5.2 mmHg, H+:176 ± 4.8, for Acyclovir + virus:
pCO2: 31 ± 0.2 mmHg, pO2: 145 ± 2.2 mmHg, H+:196
± 3.8, for the Vepesid + virus pCO2: 25 ± 0.4 mmHg,
pO2: 155 ± 2.7 mmHg, H+: 295 ± 3.9.
At concentrations of 1.56 µg/ml, the LD50 for Vepesid
against HSV-2 at three different titrations (1 TCID50, 10
TCID50, 100 TCID50) are seen in Figure 4. The LD50 for
the 1 and 10 TCID50 was found to be 100% and that at
the 100 TCID50 to be 71%.
Discussion
Herpes simplex virus infections form an important
group among viral diseases. Of these, especially those due
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Studies on the presence of antiviral characteristics of
the antineoplastic drugs used in the therapy of the cancer
today, however, are limited. In this study the antiviral
effects of Vepesid, an antineoplastic drug, against HSV-2
were examined in comparison with those of Acyclovir.
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Although literature on the antiviral effects of Vepesid
is available, there is insufficient knowledge about its use
clinically against HSV (13).
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Vepesid is a semisynthetic derivative of podophylotoxin obtained from the plant alkaloid Podophylum peltatum.
It is a highly lipophilic compound. It is one of the effective
drugs against small cell cancers. It also has effects against
non-hodgkin lymphomas, choriosarcomas, acute myelocytic leukemias and neuroblastomas (14).
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The LD50 for Vepesid against to HSV-2 at three titrations

to HSV-2 are of most importance to human health. They
cause serious infections like neonatal infections, meningitis and cervical cancer (1,7).
Today, in the treatment of herpes viral infections,
drugs like 5-iodo-2-deoxyuridine, cytarabine, vidarabine
and trifluorothymidine are used. The mechanism of action
of these drugs rests basically on their ability to inhibit the
virus specific thymidine kinase and the DNA polymerase
enzymes. However, because of the cytotoxic effects of
these drugs, their use is not widespread. Acyclovir is the
most frequently chosen and most potent of the drugs in
herpes virus infections. As is known, Acyclovir is the
acyclic nucleoside analogues of guanosine. It has a powerful antiviral activity against most herpes viruses.
Nonetheless, Acyclovir resistant mutants have been documented in recent years (2,8,9).
Although in the years of its discovery it was known as
a revolutionary step, the development of resistance
against Acyclovir in the treatment of HSV-1 and HSV-2
infections has led to the search for new antiviral drugs.
HSV infections especially present important problems in
patients in cancer chemotherapy and those immunocompromised. For this reason, any antiviral effects of the
drugs employed in cancer chemotherapy could help to a
large extent in preventing these secondary infections as
well as the emergence of resistant mutants against the
antiviral drugs (1,10-12).
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Determination of the toxicity and antiviral effects of
various drugs and compounds in cell cultures under in
vitro conditions generally depends on morphological evaluations (calculation of the LD50 due to cytopathological
effect, LD: lethal dose) (8).
In this study, however, in addition to the morphological evaluations, we also examined the cell metabolic values (Na+, K+, pH, pCO2, pO2) in the culture media. Of the
determinants of the cellular function, the Na+ ion regulates the membrane potential of the cells. Oxygen is
recovered in the provision of energy through the aerobic
glycolysis as well as the use of some of the products of
the kreb’s cycle in the synthesis of the cellular components. Carbon dioxide controls the pH of the cell culture
media. The hydrogen ion concentration in the culture is
an important criterion necessary for growth development
of the cells (15-17).
In the first group of experiments, with the aim of
determining the concentration of Vepesid and Acyclovir
that did not affect the proliferation of cells, the effects of
these two drugs at various concentration on HEp-2 cells
were investigated. Except for the 1.56 µg/ml concentration, Vepesid and Acyclovir were found to induce
cytopathological changes like nuclear enlargement, granulation and rounding of the cells at all concentrations linearly. The nontoxic concentration of Acyclovir and
Vepesid was determined morphologically to be 1.56
µg/ml. At this concentration the drugs were not found to
produce any cytopathologic changes in the cells.
Whether Acyclovir and Vepesid at this concentration
had any effect on HEp-2 cells or not was investigated by
examining parameters related directly to the cell metabo-
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lism like the cells and the Na+ ions, pH, pCO2 and pO2 of
the culture media containing the drugs. In the experiments, no significant difference was found between the
Na+ ion content of the control group and those of the
Vepesid and Acyclovir groups of nontoxic concentration.
The Na+ ion content of the culture media was found to be
138 ± 2.54 mEq/L for the control cells, 126 ± 1.65
mEq/L for the virus control, 142 ± 0.3 for the Acyclovir,
142 ± 0.4 for the Acyclovir + virus, 143 ± 1.1 for
Vepesid, and 141 ± 0.2 for the virus + Vepesid (Figure
3).
These results show that the addition of Acyclovir and
Vepesid to the HEp-2 cell growth media did not affect cellular proliferation and that the Na+ pump, a determinant
of cellular metabolism, functions normally.
Examination of the biochemical criteria shows that
while CO2 increased from 10 mmHg to 19 mmHg, O2 fell
from 200 mmHg to 160 mmHg in the cell control group.
Similarly, in culture media that contained Acyclovir and
Vepesid, CO2 content increased, while O2 content
decreased. When both the morphology and biochemical
criteria were considered, Acyclovir and Vepesid at concentrations of 1.56 µg/ml were observed not to induce
any toxic effects on the cells.
In the second group of experiments, the antiviral
effects of Vepesid and Acyclovir at this nontoxic concentration on HSV-2 were examined in comparison with the
cell and viral control groups morphologically and biochemically (Na+ ions, pH, pCO2 and pO2). In the morphologic examination, no cytopathologic changes were
observed in the cell control, whereas in the viral control,
as expected, cytopathologic changes specific to the herpes
viruses like rounding and granulation of cell and nuclear
enlargement were found.
In the culture media containing Acyclovir and Vepesid
of concentrations of 1.56 µg/ml, the Na+ ions were found
to be 138 ± 2.54 mEq/L for the cell control, and 126 ±
1.65 mEq/L for the viral control, whereas for the Acyclovir and Vepesid they were 141 ± 2.11 mEq/L and 142
± 1.86 mEq/L respectively. Here it can be understood
that in culture media containing Acyclovir and Vepesid,
viral proliferation was inhibited while the Na+ ions content
approached that of the cell control.
It can be seen clearly that apart from the Na+ ions the
pCO2, pO2 and H+ ion concentration of the culture medium also affects the inhibition of the growth of the HSV-

2 by Acyclovir and Vepesid. This can be inferred from the
observation that in the culture media containing the
drugs, just as in the control group while the CO2 and H+
ions concentrations increased, a decrease in the O2 pressure was found. This shows that the metabolic activity of
the cells continued with the O2 pressure falling because it
is used for cellular activity, whereas as metabolic bioproducts the CO2 and H+ ions concentration increased.
In addition, the LD50 of Acyclovir and Vepesid at this
concentration against 1, 10, and 100 TCID50 titers of
HSV-2 was calculated. For 1 and 10 TCID50, the LD50 was
found to be 100%, whereas for the 100 TCID50 it was
71%.
Thus, experiments in which various concentrations of
Acyclovir and Vepesid were used the antiviral effects of
these drugs against HSV-2 at 1.56 µg/ml concentrations
were determined by examination of both morphological
and biochemical criteria.
In conformity with one study, Fahad et al. found a
decrease in the Na+ ions content of the cell culture medium infected by HSV (18).
Vepesid, which is employed today as an antineoplastic
agent, has been reported in two separate studies to possess antiviral activity against HSV-1. In addition, Lewis et
al. reported that Vepesid at a concentration of 3 µg/ml
incubated the proliferation of HSV type 1 in vero (African
green monkey kidney) cells (13).
In a study by Nishiyama et al., the antiviral activity of
the semisynthetic antineoplastic drug Epipodophylotoxin
VP-16-23 against HSV-2 was observed and found to
inhibit the replication of HSV-2. The mechanism of the
antiviral action of this compound was shown to depend
upon its inhibition of both the topoisomerase II enzyme
of the cells and the viral DNA replication (19). Considering the fact that Vepesid is also from the semisynthetic
group of drugs it can be assumed to have the same mechanism of action.
The exhibition of antiviral effects against HSV-2 under
in vitro conditions by Vepesid can be extremely important
clinically. As is known, in patients receiving cancer
chemotherapy, and in bone marrow transplant patients
with HSV infections, resistance to Acyclovir develops and
the disease follows a more severe cause. The fact that
Vepesid is an anticarcinogenic drug and is used clinically
suggests that it can prevent the development of resistance to Acyclovir in herpes virus infections.
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